Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

Source:http://linkedlifedata.com/resource/pubmed/id/16421427

J. Clin. Oncol. 2006 Jan 20 24 3 500-6

Download in:

View as

General Info

PMID
16421427